Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 3 subunit L pseudogene 2 (EIF3LP2) is a human pseudogene, meaning it is a genomic DNA sequence related to the functional gene encoding the eukaryotic translation initiation factor 3 subunit L (EIF3L), but it does not produce a functional protein. Pseudogenes like EIF3LP2 generally arise via gene duplication or retrotransposition followed by accumulation of disabling mutations. EIF3LP2 is catalogued in gene databases such as NCBI Gene (ID: 143341) and Ensembl (ENSG00000233837). There is no evidence for EIF3LP2 involvement in disease, biological function, or as a drug target. EIF3LP2 is distinct from EIF3L (the protein-coding gene for a subunit of the eukaryotic translation initiation factor 3 complex that is involved in protein synthesis initiation). The pseudogene EIF3LP2 does not encode a protein and is not part of the active translation machinery in cells. No therapeutic, diagnostic, or biomarker roles have been described for EIF3LP2. This target is a validated pseudogene, not considered a druggable protein or a molecular therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 3 subunit L pseudogene 2 (EIF3LP2).